Preparing to Resume Performances and Theater Operations
First written in FY2021-Q1. 9 of 14 entries say "Advanced", first in FY2021-Q2. Latest entry: FY2024-Q2.
No other company in this theme has enough history to compare yet.
- FY2024-Q2AdvancedAnnual report
「From April, performances were presented in a two-part schedule, and sales of single-act seats also resumed in June, among other measures, allowing the Company to return to the performance format used before the COVID-19 pandemic.」
The Company changed from a three-part schedule to a day-and-evening two-part schedule, and resumed sales of single-act seats in June. The return to the pre-pandemic performance format became more concrete. - FY2024-Q1Changed from a three-part schedule to day-and-evening performancesAnnual report
「The Company had previously held three-part performances, but beginning with the April production, the Phoenix Festival April Grand Kabuki, performances have been presented in a day-and-evening two-part schedule.」
The operating format changed from the three-part schedule established under infection-prevention measures to a day-and-evening two-part schedule beginning with the April performances. The theater business segment loss decreased from the same period of the previous year. - FY2023RestatedAnnual report
「Kabukiza held three-part performances in compliance with infection-prevention guidelines and worked to improve profitability.」
Operations continued with performances combining infection-prevention measures and a three-part schedule, while some performances were canceled due to an increase in infections. - FY2023-Q3Continuation of three-part performances and cancellation of some performancesAnnual report
「Kabukiza held performances in compliance with infection-prevention guidelines and worked to improve profitability.」
Operations continued with infection-prevention measures and three-part performances, among other measures, while all performances of the July Grand Kabuki were canceled partway through the run due to a sharp increase in infections among stage personnel. Understudy performers were assigned to absent performers, and measures were also taken to continue performances wherever possible. - FY2023-Q2Continuation of three-part performances and cancellation of some performancesAnnual report
「Kabukiza held performances in compliance with infection-prevention guidelines and worked to improve profitability. Operations proceeded smoothly through the June Grand Kabuki, but due to a sharp increase in COVID-19 infections among stage personnel, all performances of the July Grand Kabuki were canceled partway through the run.」
Operations continued with infection-prevention measures and three-part performances, while all performances of the July Grand Kabuki were canceled partway through the run due to a sharp increase in infections among stage personnel. - FY2023-Q1AdvancedAnnual report
「To prevent the spread of COVID-19, the number of seats available for sale was kept at approximately 50% of capacity through December 2021, but was increased to approximately 70% from performances in January 2022.」
In operating performances subject to infection-prevention measures, the number of seats available for sale was increased from approximately 50% of capacity to approximately 70% from January 2022. - FY2022AdvancedAnnual report
「Kabukiza held three-part performances throughout the year.」
Operations after the resumption of performances became established as three-part performances throughout the year. The disclosure also noted operational progress toward improving profitability, including raising seating capacity from January. - FY2022-Q3AdvancedAnnual report
「Kabukiza held three-part performances from March through November. Following the declaration of a state of emergency, some dates of the April Grand Kabuki and May Grand Kabuki were canceled, but performances were held in compliance with infection-prevention guidelines.」
After operations resumed, the Company continued and further implemented three-part performances from March through November while complying with infection-prevention measures. Although some dates were canceled, performances were held at Kabukiza. - FY2022-Q2AdvancedAnnual report
「Kabukiza operated on a three-part performance schedule from March through August. Although some dates of "April Grand Kabuki" and "May Grand Kabuki" were cancelled following the declaration of a state of emergency, performances were held in compliance with infection-prevention guidelines.」
After operations resumed, the Company continued and further implemented three-part performances from March through August while complying with infection-prevention measures. Although some performances were canceled, performances were held at Kabukiza. - FY2022-Q1AdvancedAnnual report
「To prevent the spread of COVID-19, theater productions at Shochiku's directly operated theaters continued to limit audience capacity, implement thorough infection-control measures and stage performances with due regard for audience safety and peace of mind. However, following the declaration of a state of emergency, some performances scheduled for April and May were canceled for part or all of their runs.」
Operations continued with performances combining infection-prevention measures and restricted seating capacity, including performances in March, April, and May. Although some performances were canceled pursuant to the state of emergency, operations after the resumption of business became more concrete. - FY2021AdvancedAnnual report
「Performances resumed in August, and the first four-performance schedule was operated through December, with one production in each part and no intermissions between parts. Beginning with the January production, Kotobuki Hatsuharu Grand Kabuki, the schedule changed to three parts, with 2 productions in each part. The theater also recovered to the point of generating a monthly operating profit in February.」
Operations progressed from preparations to resume performances to actual implementation. Performances combining four- and three-part schedules, infection-prevention measures, and audience restrictions were held, and Kabukiza achieved a monthly operating profit in February. - FY2021-Q3AdvancedAnnual report
「Performances at Kabukiza were canceled from March through July, but the March Grand Kabuki was recorded without an audience and distributed free of charge on a video-sharing website, receiving a favorable response. The Ichikawa Danjuro XIII Hakuen Name-Taking Performance, scheduled for May through July, was postponed. Beginning with the August Grand Kabuki, performances resumed under comprehensive measures and in accordance with infection-prevention guidelines, using a four-performance schedule for the first time.」
The Company moved beyond preparations to resume operations and resumed performances at Kabukiza by combining a four-performance schedule, infection-prevention measures, and an audience utilization rate of no more than 50%. At Shinbashi Enbujo, audiences were welcomed for the first time in 7 months, while Shochikuza in Osaka held a live performance streamed without an audience. - FY2021-Q2AdvancedAnnual report
「The company resumed performances of “Hachigatsu Kabuki” under a comprehensive system complying with infection-prevention guidelines, presenting it for the first time in a four-part format. Although capacity was limited to 50% or less, customers who had been eagerly awaiting the resumption responded positively to the theater’s measures, and the performances concluded without any infections among the audience or performers through the final performance.」
The Company moved beyond the preparation stage and actually resumed performances at Kabukiza by combining infection-prevention guidelines, seating capacity of no more than 50%, and a four-performance schedule. - FY2021-Q1First statedAnnual report
「During this period, we proceeded with preparations to resume operations. However, as a state of emergency was declared, all performances produced by the Company, including those at directly operated theaters, were ultimately canceled or postponed during the cumulative first quarter of the current fiscal year.」
The first disclosure that preparations to resume operations were undertaken during the period when performances were canceled or postponed. No specific timing or details of the preparations were provided.